RHEUMATOLOGY INTERNATIONAL 期刊简介

RHEUMATOLOGY INTERNATIONAL
英文简介:

RHEUMATOLOGY INTERNATIONAL is an independent journal reflecting world-wide progress in the research, diagnosis and treatment of the various rheumatic diseases. It is designed to serve researchers and clinicians in the field of rheumatology.

RHEUMATOLOGY INTERNATIONAL will cover all modern trends in clinical research as well as in the management of rheumatic diseases. Special emphasis will be given to public health issues related to rheumatic diseases, applying rheumatology research to clinical practice, epidemiology of rheumatic diseases, diagnostic tests for rheumatic diseases, patient reported outcomes (PROs) in rheumatology and evidence on education of rheumatology. Contributions to these topics will appear in the form of original publications, short communications, editorials, and reviews. "Letters to the editor" will be welcome as an enhancement to discussion. Basic science research, including in vitro or animal studies, is discouraged to submit, as we will only review studies on humans with an epidemological or clinical perspective. Case reports without a proper review of the literatura (Case-based Reviews) will not be published. Every effort will be made to ensure speed of publication while maintaining a high standard of contents and production.

Manuscripts submitted for publication must contain a statement to the effect that all human studies have been reviewed by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in an appropriate version of the 1964 Declaration of Helsinki. It should also be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under study should be omitted.

中文简介:(来自Google、百度翻译)

《国际风湿病学》是一份独立的杂志,反映了世界范围内在各种风湿性疾病的研究,诊断和治疗方面的进展。它旨在为风湿病学领域的研究人员和临床医生提供服务。
风湿病学国际将涵盖临床研究以及风湿病管理的所有现代趋势。将特别强调与风湿病有关的公共卫生问题,将风湿病学研究应用于临床实践,风湿病流行病学,风湿病的诊断测试,风湿病学患者报告的结果 (pro) 以及风湿病学教育的证据。对这些主题的贡献将以原始出版物,简短通讯,社论和评论的形式出现。欢迎 “给编辑的信” 作为讨论的增强。不鼓励提交包括体外或动物研究在内的基础科学研究,因为我们只会从流行病学或临床角度审查关于人类的研究。没有对文献进行适当审查的案例报告 (基于案例的审查) 将不会发布。将尽一切努力确保出版速度,同时保持高标准的内容和生产。
提交出版的手稿必须包含一份声明,大意是所有人类研究都经过了适当的伦理委员会的审查,因此已经按照伦理标准进行了《赫尔辛基1964宣言》的适当版本。案文中还应明确指出,所有人在纳入研究之前均已知情同意。可能透露被研究对象身份的细节应省略。

期刊ISSN
0172-8172
影响指数
2.605
最新CiteScore值
4.00 查看CiteScore评价数据
最新自引率
7.90%
官方指定润色网址
https://www.deeredit.com/?type=ss1
投稿语言要求

Improve the quality of the paper, eliminate grammar and spelling errors, increase readability, ensure accurate communication of viewpoints, enhance academic reputation, and increase the chances of the paper being accepted.

建议点击这个网址:https://www.deeredit.com/?type=ss2,资深审稿专家为您评估稿件质量,提供针对性改进建议,最终可助您极大提升目标期刊录用率

期刊官方网址

hot

https://www.peipusci.com/?type=9
杂志社征稿网址

hot

https://www.peipusci.com/?type=10
通讯地址
SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013
偏重的研究方向(学科)
医学-风湿病学
出版周期
Tri-annual
出版年份
1981
出版国家/地区
GERMANY
是否OA
No
SCI期刊coverage
Science Citation Index Expanded(科学引文索引扩展)
NCBI查询
PubMed Central (PMC)链接 全文检索(pubmed central)
RHEUMATOLOGY INTERNATIONAL 期刊中科院JCR 评价数据
最新中科院JCR分区
大类(学科)
小类(学科)
综述期刊
医学
RHEUMATOLOGY(风湿病学)4区
最新的影响因子
2.605
最新公布的期刊年发文量
年度总发文量 研究类文章占比
301 67.77%
总被引频次 66
影响因子趋势图
近年的影响因子趋势图(整体平稳趋势)

2022年预警名单预测最新

RHEUMATOLOGY INTERNATIONAL 期刊CiteScore评价数据
最新CiteScore值
4.00
年文章数 301
SJR
0.806
SNIP
1.015
CiteScore排名
序号 类别(学科) 排名 百分位
1 Medicine Rheumatology #27/56
2 Medicine Immunology and Allergy #103/182
3 Medicine Immunology #126/202
CiteScore趋势图
CiteScore趋势图
RHEUMATOLOGY INTERNATIONAL 投稿经验(由下方点评分析获得,0人参与,1714人阅读)
投稿录用比例: 约75%
审稿速度: 平均16.月
分享者 点评内容
没有更多了~
Copyright © 2014-2019 晟斯医学 All Rights Reserved. 备案号:苏ICP备11037034号-5 版权所有:南京孜文信息咨询有限公司